SEC Company Response from Entera Bio Ltd. (ENTX, ENTXW) (CIK 0001638097) (ENTX) — Jan 19, 2018

Entera Bio Ltd. (ENTX, ENTXW) (CIK 0001638097)
Date: Jan. 19, 2018 · CIK: 0001638097 · Accession: 0000950103-18-000611

View on Edgar

AI Filing Summary & Sentiment

Sentiment

Urgency

Document Type

Confidence

SEC Posture

Company Posture

Summary

Reasoning

File numbers found in text: 333-221472

Date

January 19, 2018

Author

ENTERA BIO LTD.

Form

CORRESP

Company

Entera Bio Ltd. (ENTX, ENTXW) (CIK 0001638097)

Letter

Division of Corporation Finance Ms. Mary B. Breslin Re: Entera Bio Ltd. Registration Statement on Form F-1 Registration No. 333-221472

Dear Ms. Sarmento and Ms. Breslin,

Pursuant to Rule 461 under the Securities Act of 1933, as amended, the undersigned registrant hereby requests that the effective date for the Registration Statement referred to above be accelerated so that it will be declared effective at 4:00 p.m. Eastern Daylight Time on January 23, 2018 or as soon thereafter as is practicable. By separate letter, the underwriters of the issuance of the securities being registered join in this request for acceleration.

Please do not hesitate to contact Sophia Hudson of Davis Polk & Wardwell LLP at (212) 450-4762 with any questions or comments with respect to this letter.

[Signature Page Follows]

Sincerely,
ENTERA BIO LTD.

Show Raw Text

CORRESP
1
filename1.htm

        Entera Bio Ltd.

        Kiryat Hadassah

        Minrav Building – Fifth Floor

        Jerusalem 9112002

        Israel

        January 19, 2018

Division of Corporation Finance

U.S. Securities and Exchange Commission

100 F Street, N.E.

Washington, D.C. 20549-3628

 Attn: Ms. Ada D. Sarmento

Ms. Mary B. Breslin

    Re:
    Entera Bio Ltd.

Registration Statement on Form F-1

Registration No. 333-221472

Dear Ms. Sarmento and Ms. Breslin,

Pursuant to Rule 461 under the Securities Act of 1933, as amended,
the undersigned registrant hereby requests that the effective date for the Registration Statement referred to above be accelerated
so that it will be declared effective at 4:00 p.m. Eastern Daylight Time on January 23, 2018 or as soon thereafter as is practicable.
By separate letter, the underwriters of the issuance of the securities being registered join in this request for acceleration.

Please do not hesitate to contact Sophia Hudson of Davis
Polk & Wardwell LLP at (212) 450-4762 with any questions or comments with respect to this letter.

[Signature Page Follows]

Sincerely,

    ENTERA BIO LTD.

    By:
    /s/ Phillip Schwartz

    Name:	Phillip Schwartz

    Title:	Chief Executive Officer

Via EDGAR

CC: Sophia Hudson, Davis Polk & Wardwell LLP

SecProbe.io